Navigation Links
Selexis and Neogenix Oncology Announce Agreement on Antibody Project
Date:9/22/2009

GENEVA and GREAT NECK, N.Y., Sept. 22 /PRNewswire/ -- Selexis SA ("Selexis") and Neogenix Oncology, Inc. ("Neogenix") today jointly announced a Research Services Agreement for the rapid development of a high-performance CHO based production cell line expressing an undisclosed Neogenix antibody. The cell line will be developed by Selexis scientists utilizing the industry leading Selexis SURE Cell Line Development(TM) Platform.

"We are very appreciative to have this opportunity to establish a strong partnership with the world class scientists at Neogenix as the company develops innovative therapies for the management of serious and difficult to treat cancers," said Dr Igor Fisch, CEO and co-founder of Selexis SA. "By targeting antigens shown only to be associated with tumor cells, Neogenix is in a unique position with regards to treating cancer, making this a very special program to us."

"After careful consideration Neogenix chose Selexis for this important project based on their industry reputation and proven record of performance in being able to quickly generate production cell lines to support high demand antibody programs like ours," said Dr. Andrew Bristol, Vice President of Research and Development of Neogenix.

Neogenix Oncology, Inc. announced last week that the Food and Drug Administration (FDA) has granted permission for the company to begin a Phase I trial with its first therapeutic antibody, NPC-1C under its first IND (Investigational New Drug Application). This first human trial will evaluate the safety of NPC-1C in patients with late stage pancreatic or colorectal cancer. The project being undertaken with Selexis will make an important contribution toward the development and potential commercialization of this and other potential Neogenix products.

About Selexis:

Selexis is a privately held Swiss biotechnology comp
'/>"/>

SOURCE Selexis SA
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Selexis and NKT Therapeutics Enter Into Research Services Agreement
2. Selexis Now Offering Rapid-Development of Human Cell Line With FDA Approval Pedigree
3. US Oncology Named to InformationWeek 500 as Top User of Business Technology
4. Bayer and Onyx Announce Nexavar Data Presentations at the Joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress
5. ESMO Online Innovation Helps the Oncology Community Share Knowledge and Enhance Practice
6. NCCN Holds Oncology Research Best Practices Conference
7. CBI Announces Multi-Stakeholder Collaboration Panel at Upcoming Effective Oncology Benefit Management Forum
8. DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop
9. Managing Myeloma Website Launches an Interactive Forum for Oncology Nurses, Wins 2009 Gold Hermes Creative Award for Site Overall
10. Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine(TM) For Prostate Conditions With Start-Up of Phase 2 BPH Trial
11. Arizona Oncology Opens Radiation Facility at Phoenix Baptist Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Hundreds of thousands of people ... is why liposuction regularly ranks among the top five most popular cosmetic surgeries ... more than a way to slim down a silhouette for swimsuit season. Military ...
(Date:7/6/2015)... ... July 06, 2015 , ... Understanding the ... and ADVOCATE is leading the transition. ADVOCATE, the only 100% radiology, revenue cycle ... 10 Tips for ICD-10. The ten tips are timely and relevant guidelines to ...
(Date:7/6/2015)... ... 2015 , ... Cancer Hope Network (CHN) has relaunched their ... to chat with the CHN patient services team and connect with a Support ... often the most traumatic experience of a person’s life,” said CHN Executive Director, ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... Carlson & Associates has once again teamed up with Family Emergency Shelter Coalition ... to move toward self-sufficiency. FESCO was created especially to provide emergency services and ...
(Date:7/6/2015)... ... ... With a new community program in the Livonia, Canton and Plymouth areas, Bowker ... charity campaign to raise funds in support of the health and safety of the ... is a coalition created especially to educate and empower teens, bringing awareness to the ...
Breaking Medicine News(10 mins):Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 2Health News:Learn How CoolSculpting® and Liposuction in Virginia Beach Help Military Members Stay the Course 3Health News:ADVOCATE Takes the Lead to Ensure ICD-10 Success: “Top 10 Tips for ICD-10” 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3
... YORK, March 1, 2012 A nutrient found in the ... disease (CHD) in women with high cholesterol, according to a ... The study, published online in the European Journal of ... found in the dark meat of turkey and chicken, as ...
... By Ellin Holohan HealthDay Reporter , THURSDAY, March ... trans fats in your diet, especially if you are an ... risk of stroke among postmenopausal women who ate the highest ... and packaged products. The research, done at the University ...
... A team of 18 researchers at Moffitt Cancer Center ... sarcoma patients with a combination of implanted dendritic cells (immune ... than 50 percent of their trial patients with tumor-specific immune ... study was published in a recent issue of the ...
... 2012) Imaging amino acid transporters with positron ... significantly alter intended management plans for patients with ... issue of The Journal of Nuclear Medicine ... radiopharmaceutical 3,4-dihydroxy-6-F-18-fluoro-L-phenylalanine (F-18-DOPA), physicians changed the intended management ...
... first audit of leukaemia treatment and survival in Northern Ireland ... shown that survival rates for the disease here are at ... For children with the disease, survival has improved dramatically ... the current level of over 80 per cent for five ...
... THURSDAY, March 1 (HealthDay News) -- Teens with chronic fatigue ... as joint and muscle pain, may benefit from an Internet-based ... Researchers in the Netherlands studied teens with the debilitating ... better or had recovered after six months of the Web-based ...
Cached Medicine News:Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 2Health News:Nutrient found in dark meat of poultry, some seafood, may have cardiovascular benefits 3Health News:Trans Fats May Raise Stroke Risk in Older Women 2Health News:Trans Fats May Raise Stroke Risk in Older Women 3Health News:Researchers find sarcoma tumor immune response with combination therapy 2Health News:PET tracer changes management plan for brain tumor patients 2Health News:New study reveals more people surviving leukaemia and pancreatic cancer in Northern Ireland 2Health News:New study reveals more people surviving leukaemia and pancreatic cancer in Northern Ireland 3Health News:Web-Based Therapy May Help Teens With Chronic Fatigue 2
(Date:7/6/2015)... July 6, 2015 /CNW/ - The Canadian Pharmacists Association (CPhA) ... strategy to ensure that all Canadians have the opportunity ... (human papillomavirus) through immunization. The lack of access to ... Canada is needlessly putting the health of ... as HPV, continue to pose a significant threat to ...
(Date:7/6/2015)... July 6, 2015   BioClinica®, Inc ., ... today announced that it has acquired a leading ... , Inc. (Medici).  The acquisition includes affiliates ... Medici also provides a lost-to-follow-up patient locate service ...  Together with Medici, BioClinica will offer ...
(Date:7/6/2015)... 29, 2015 Research and ... "Urinary Slings Market in the US 2015-2019" ... the Urinary Slings market in the US to grow ... 2014-2019. This report covers the present scenario and ... the US for the period 2015-2019. To calculate the ...
Breaking Medicine Technology:CPhA Calls for HPV Strategy for Young Men to Save Lives 2BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3United States Urinary Slings Market 2015-2019 - Vaginal Slings (TVT, TOT, and Single-incision) & Male Slings (Artificial Urinary Sphincters) 2
... May 9, 2012 /PRNewswire-iReach/ -- Global Information ... in rapidly expanding Protein Therapy market: ... Protein-based therapies have become one of the most ... ranging from cancer to metabolic disorders. While worldwide healthcare spending ...
... 2012  Millstone Medical Outsourcing announced today that the ... Quality Systems.  As a seasoned quality specialist with ... for managing the quality systems for all of ... working closely with customers to ensure the highest ...
Cached Medicine Technology:New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015 2Millstone Medical Outsourcing Hires New Vice President Quality 2
... fully automated system with,a disposable head ... refractive procedure known,as Epi-Lasik. The Epi-K ... from the,Bowmans membrane leaving a pristine,optical ... structural integrity,of the stroma and is ...
... brings it all together.,Cynergy III allows you ... and Cynergy PL. With its combination,of pulse ... system,the Cynergy III is the most exciting ... a true workstation, able to treat a,wider ...
... XLTEK lets you choose how to configure your ... the study to be performed we recommend ... your budget and clinical needs. How do we ... listen. The result? Kortex. The system that lets ...
... ideal as a primary chemistry-immuno analyzer ... laboratories or as a dedicated specialty ... consolidate chemistry-immuno testing with Olympus 122 ... specific proteins, esoteric chemistries and tests ...
Medicine Products: